Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Clinical Nuclear Medicine|March 22, 2006
Reversal of hypermetabolic brown adipose tissue in F-18 FDG PET imagingCarl R Christensen, Paige B Clark, Kathryn A Morton
AJR. American Journal of Roentgenology|February 22, 2007
Brain abnormalities detected on whole-body 18F-FDG PET in cancer patients: spectrum of findingsErin Stubbs, Jonathan Kraas, Kathryn A Morton, et al.
Clinical Nuclear Medicine|March 15, 2005
The scintigraphic appearance of subcapsular parathyroid adenomasJonathan Kraas, Paige B Clark, Nancy D Perrier, et al.
Archives of Surgery (Chicago, Ill. : 1960)|March 22, 2006
Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanomaPaige B Clark, Victoria Soo, Jonathan Kraas, et al.
The American Surgeon|July 11, 2003
Experienced scintigraphers contribute to success of minimally invasive parathyroidectomy by skilled endocrine surgeonsPaige B Clark, Doug Case, Nat E Watson, et al.
Clinical Nuclear Medicine|December 10, 2003
Enhanced scintigraphic protocol required for optimal preoperative localization before targeted minimally invasive parathyroidectomyPaige B Clark, Doug Case, Nat E Watson, et al.
Annals of Surgical Oncology|April 14, 2005
Is parathyroid carcinoma indeed a lethal disease?Kenneth P Kleinpeter, James F Lovato, Paige B Clark, et al.
Diabetes Technology & Therapeutics|July 8, 2009
Enhanced cholinergic response in pancreata of nonhuman primates with impaired glucose tolerance shown on [18F]fluorobenzyltrozamicol positron emission tomographyPaige B Clark, Kylie Kavanagh, H Donald Gage, et al.
Journal of Computer Assisted Tomography|May 30, 2009
Left ventricular infarct size assessed with 0.1 mmol/kg of gadobenate dimeglumine correlates with that assessed with 0.2 mmol/kg of gadopentetate dimeglumineMonravee Tumkosit, Chirapa Puntawangkoon, Tim M Morgan, et al.
International Journal of Radiation Oncology, Biology, Physics|October 11, 2005
A prospective evaluation of the impact of 18-F-fluoro-deoxy-D-glucose positron emission tomography staging on survival for patients with locally advanced esophageal cancerA William Blackstock, Michael R Farmer, James Lovato, et al.
Pageof 2